The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells

Hepatology

Volumn 37, Issue 5, 2003, Pages 1034-1042

  Gascon Barré, Marielle ^a,b   Demers, Christian ^a   Mirshahi, Ali ^a,b   Néron, Stéphane ^a,b   Zalzal, Sylvia ^b   Nanci, Antonio ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CELL NUCLEUS RECEPTOR; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D NUCLEAR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL ISOLATION; CELL LINE; CELL POPULATION; COLON ADENOCARCINOMA; ENDOCRINE SYSTEM; ENDOTHELIUM CELL; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KUPFFER CELL; LIVER; LIVER CELL; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER SINUSOID; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RNA ANALYSIS; STELLATE CELL;

EID: 0038713221     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50176     Document Type: Article

References (50)

1. 3 receptor in rat liver and kidney. Endocrinology 1991;129:2318-2324.
2. 3 receptor in the male rat. Biochem Biophys Res Commun 1991;181:611-616.
3. Segura C, Alonso M, Fraga C, Garcia-Caballero T, Diéguez C, Pérez-Fernandez R. Vitamin D receptor ontogenesis in rat liver. Histochem Cell Biol 1999;112:163-167.
4. Baran DT, Milne ML. 1,25-dihydroxyvitamin D increases hepatocytes cytosolic calcium levels. A potential regulator of the D-25 hydroxylase. J Clin Invest 1986;77:1622-1626.
5. Baran DT, Kelly AM. Lysophosphatidylinositol: a potential mediator of 1,25-dihydroxyvitamin D-induced increments in hepatocyte cytosolic calcium. Endocrinology 1988;122:930-934.
6. 3. J Cell Biochem 2000;78:34-46.
7. Éthier C, Kestekian R, Beaulieu C, Dubé C, Havrankova J, Gascon-Barré M. Vitamin D depletion retards the normal regeneration process following partial hepatectomy in the rat. Endocrinology 1990;126:2947-2959.
8. 3 in hypocalcemia. J Hepatol 1997;26:659-668.
9. 3. J Cell Physiol 1989;139:354-360.
10. 3 on changes in the activities of some cytoplasmic and nuclear protein kinases during liver regeneration. J Cell Physiol 1983;115:297-304.
11. 3H-25 hydroxyvitamin D production by the rachitic rat liver in vitro. Calcif Tissue Int 1983;35:461-464.
12. 3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest 1984;74:1540-1544.
13. 3 administration. Am J Physiol 2003;284:E138-E147.
14. 3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989;83:1903-1915.
15. Manolagas SC, Yu XP, Girasole G, Bellido T. Vitamin D and the hematolymphopoietic tissue: a 1994 update. Semin Nephrol 1994;4:129-143.
16. 3. J Biol Chem 1993;268:27371-27380.
17. Solomon C, Sebag M, White JH, Rhim J, Kremer R. Disruption of vitamin D receptor-retinoid X receptor heterodimer formation following ras transformation of human keratinocytes. J Biol Chem 1998;273:17573-17578.
18. Gascon-Barré M, Haddad P, Provencher SJ, Bilodeau S, Pecker F, Lotersztajn S, Vallieres S. Chronic hypocalcemia of vitamin D deficiency leads to lower resting intracellular calcium concentrations in rat hepatocytes. J Clin Invest 1994;93:2159-2167.
19. Guguen-Guillouzo C, Campion JP, Brisset P, Glaise D, Lannois B, Bourel M, Guillouzo A. High yield preparation of isolated human adult preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver. Cell Biol Int Rep 1982;6:625-628.
20. Knook DL, Sleyster CC. Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp Cell Res 1976;99:444-449.
21. Néron S. Expression hépatique des genes du facteur de croissance des hepatocytes et de son récepteur, le proto-oncogène c-met, après administration de térachlorure de carbone. Influence du statut en vitamine D [M.Sc. thesis]. Montreal, Canada: Université de Montréal, 1995.
22. Paradis K, Le ONL, Russo P, St-Cyr M, Fournier H, Bu D. Characterization and response to interleukin 1 and tumor necrosis factor of immortalized murine biliary epithelial cells. Gastroenterology 1995;109:1308-1315.
23. Blouin MJ, Lamy I, Loranger A, Noël M, Corlu A, Guguen-Guillouzo C, Marceau N. Specialization switch in differentiating embryonic rat liver progenitor cells in response to sodium butyrate. Exp Cell Res 1995;217:22-30.
24. 3 hydroxylases and the drug metabolizing enzyme CYP3A4 in the human fetal intestine. Clin Endocrinol 2003 (in press).
25. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-5299.
26. Chew CS, Säfsten B, Flemström G. Calcium signaling in cultured human and rat duodenal enterocytes. Am J Physiol 1998;275:G286-G304.
27. 3 receptor cDNA. Proc Natl Acad Sci U S A 1988;85:1005-1009.
28. 3 24-hydroxylase. Biochemistry 1993;32:76-82.
29. Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985;13:2485-2502.
30. Bendayan M. Colloidal gold post-embedding immunocytochemistry. Prog Histochem Cytochem 1995;29:1-159.
31. Frens G. Controlled nucleation for the regulation of particle size in monodispersed gold suspensions. Nature 1973;241:20-22.
32. 3 24-hydroxylase (CYP24) promoter. J Biol Chem 1996;271:29715-29721.
33. Haussler MR, Witfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998;13:325-349.
34. 3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells. Mol Endocrinol 2001;15:1127-1139.
35. 3. Mol Pharmacol 2001;60:1399-1406.
36. 3-modified Caco-2 cell monolayers. J Pharmacol Exp Ther 1999;289:1134-1142.
37. Mäkinen J, Frank C, Jyrkkärinne J, Gynther J, Cadberg C, Honkakoski P. Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol 2002;62:366-378.
38. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002;296:1313-1316.
39. 3 by the dog liver. Can J Physiol Pharmacol 1986;64:699-702.
40. 3. Endocrinology 1991;129:2335-2344.
41. He RK, Gascon-Barré M. Influence of the vitamin D status on the early response to carcinogen exposure in the rat. J Pharmacol Exp Ther 1997;281:464-469.
42. 3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2. Anticancer Res 2000;20:723-728.
43. Bowman AR, Epstein S. Drug and hormone effects on vitamin D metabolism. In: Feldman D, Glorieux FH, Pike JW, eds. Vitamin D. San Diego: Academic, 1997:797-829.
44. 3 toxicity in the rat. Toxicol Appl Pharmacol 1978;43:125-135.
45. Hahn TJ, Birge SJ, Scharp CR, Avioli LV. Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest 1972;51:741-748.
46. Silver J, Neale G, Thompson GR. Effect of phenobarbitone treatment on vitamin D metabolism in mammals. Clin Sci Mol Med 1974;46:433-448.
47. 3 in the dog. Am J Physiol 1986;251: G627-G635.
48. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E, et al. 25-hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 2001;66:287-292.
49. Thomas MG, Sylvester PA, Newcomb P, Longman RJ. Vitamin D receptor expression in colorectal cancer. J Clin Pathol 1999;52:181-183.
50. 3 receptor mRNA in the proliferation of hepatocellular carcinoma. Hepatogastroenterology 2000;47:468-472.